Tingl Exfoliating Pads

Description

TINGL Exfoliating Pads are formulated for topical application. These pads are designed to provide exfoliation through a combination of active ingredients that promote skin renewal. The product is presented in a convenient pad form, allowing for easy application and consistent use. Each pad is saturated with a solution that aids in the removal of dead skin cells, enhancing skin texture and appearance.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. A thin layer should be applied to the entire affected area one to two times daily, taking care to avoid the eye area. It is important to allow the product to absorb completely before applying any additional products.

To minimize the risk of excessive drying of the skin, it is recommended to initiate treatment with one application daily. The frequency may be gradually increased to two times daily as needed or as directed by a physician. In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day. It is essential to note that the skin may require time to build tolerance for consistent use.

After each use, the cap should be tightened securely to prevent the pads from drying out.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with a Poison Control Center is advised.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to exercise caution when using this medication, particularly in conjunction with other topical acne treatments. The concurrent use of multiple topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

Patients should be instructed to avoid contact with sensitive areas, including the eyes, lips, and mouth. Should accidental contact occur, it is imperative to flush the affected area thoroughly with water to minimize potential irritation.

Additionally, this product should be stored out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is intended for external use only. The use of this product in conjunction with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate these effects.

Additionally, care should be taken to avoid contact with the eyes, lips, and mouth. Should contact occur, it is advised to flush the affected area thoroughly with water to reduce the risk of adverse reactions.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. To mitigate these effects, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the products is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when combining treatments.

Packaging & NDC

Below are the non-prescription pack sizes of Tingl Exfoliating Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

The safety of this product during pregnancy has not been established. Use of salicylic acid is contraindicated in pregnancy due to potential risk to the fetus. Therefore, pregnant women should avoid using this product to mitigate any potential risks associated with fetal exposure.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data regarding its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is crucial to emphasize the importance of seeking immediate medical assistance or contacting a Poison Control Center if the medication is swallowed. This information is vital for ensuring patient safety and preventing potential harm.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. However, no specific storage or handling instructions are provided. It is recommended that healthcare professionals refer to standard storage practices for similar products to ensure optimal quality and efficacy.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients regarding the potential for increased skin sensitivity to the sun due to the presence of alpha hydroxy acid (AHA) in the formulation. Patients are advised to use sunscreen, wear protective clothing, and limit sun exposure while using the product and for one week following its use. No additional information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Tingl Exfoliating Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)